Molecular tumorigenesis of the skin

Yoshiaki Kubo1, Yoshihiro Matsudate, Nozomi Fukui

  • 1Department of Dermatology, Institute of Health Biosciences, the University of Tokushima Graduate School.

Insights

This review details the molecular basis of common skin tumors, including seborrheic keratosis, squamous cell carcinoma, and melanoma. It highlights key molecular events and targeted therapies for skin cancer development.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Skin tumors arise from accumulated genetic and epigenetic alterations in skin cells.
  • Common skin tumors include benign seborrheic keratosis and malignant squamous cell carcinoma and melanoma.
  • Understanding molecular tumorigenesis is crucial for developing targeted therapies.

Purpose of the Study:

  • To review recent advancements in the molecular tumorigenesis of common skin tumors.
  • To present current research on the molecular pathways involved in skin cancer development.
  • To discuss targeted therapeutic strategies based on molecular findings.

Main Methods:

  • Literature review of molecular tumorigenesis in skin cancers.
  • Analysis of genetic and epigenetic events in tumor development.
  • Synthesis of current research findings and therapeutic targets.

Main Results:

  • Key molecular events driving seborrheic keratosis, squamous cell carcinoma, and melanoma have been identified.
  • Several molecular targets for therapeutic intervention have been discovered.
  • Current research provides insights into the complex molecular landscape of skin tumors.

Conclusions:

  • Molecular insights are advancing the understanding and treatment of skin tumors.
  • Targeted therapies hold promise for improving outcomes in skin cancer patients.
  • Continued research into molecular tumorigenesis is essential for future therapeutic innovations.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Tumor Progression02:07

Tumor Progression

3.1K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K